Terms: = Thyroid cancer AND uPA
44 results:
1. MMP-11 expression in early luminal breast cancer: associations with clinical, MRI, pathological characteristics, and disease-free survival.
Molière S; Lodi M; Leblanc S; Gressel A; Mathelin C; Alpy F; Chenard MP; Tomasetto C
BMC Cancer; 2024 Mar; 24(1):295. PubMed ID: 38438841
[TBL] [Abstract] [Full Text] [Related]
2. In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic thyroid cancer Cell Lines.
Baldini E; Presutti D; Favoriti P; Santini S; Papoff G; Tuccilli C; Carletti R; Di Gioia C; Lori E; Ferent IC; Gagliardi F; Catania A; Pironi D; Tripodi D; D'Andrea V; Sorrenti S; Ruberti G; Ulisse S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409084
[TBL] [Abstract] [Full Text] [Related]
3. Quercetin Has Antimetastatic Effects on Gastric cancer Cells via the Interruption of upa/upaR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα.
Li H; Chen C
Integr Cancer Ther; 2018 Jun; 17(2):511-523. PubMed ID: 28627240
[TBL] [Abstract] [Full Text] [Related]
4. Role of LRP-1 in cancer cell migration in 3-dimensional collagen matrix.
Appert-Collin A; Bennasroune A; Jeannesson P; Terryn C; Fuhrmann G; Morjani H; Dedieu S
Cell Adh Migr; 2017 Jul; 11(4):316-326. PubMed ID: 27463962
[TBL] [Abstract] [Full Text] [Related]
5. [All-trans retinoic acid improves iodine uptake of thyroid cancer cells via repressing transcriptional activity of β-catenin].
Lan L; Deng W; Chen HL; Huo LL; Deng LL; Zhang GY; Luo Y
Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(7):553-8. PubMed ID: 26902198
[TBL] [Abstract] [Full Text] [Related]
6. Up-regulation of urinary-type plasminogen activator correlates with high-risk papillary thyroid carcinoma with BRAF(V600E) mutation and its possible molecular mechanism.
Wakasa T; Li Y; Bai Y; Liu Z; Ozaki T; Mori I; Miyauchi A; Kakudo K; Nakamura M
Pathol Res Pract; 2014 Nov; 210(11):733-8. PubMed ID: 25085839
[TBL] [Abstract] [Full Text] [Related]
7. Non-thermal atmospheric pressure plasma inhibits thyroid papillary cancer cell invasion via cytoskeletal modulation, altered MMP-2/-9/upa activity.
Chang JW; Kang SU; Shin YS; Kim KI; Seo SJ; Yang SS; Lee JS; Moon E; Lee K; Kim CH
PLoS One; 2014; 9(3):e92198. PubMed ID: 24667444
[TBL] [Abstract] [Full Text] [Related]
8. TMPRSS4 induces cancer cell invasion through pro-upa processing.
Min HJ; Lee MK; Lee JW; Kim S
Biochem Biophys Res Commun; 2014 Mar; 446(1):1-7. PubMed ID: 24434139
[TBL] [Abstract] [Full Text] [Related]
9. TMPRSS4 upregulates upa gene expression through JNK signaling activation to induce cancer cell invasion.
Min HJ; Lee Y; Zhao XF; Park YK; Lee MK; Lee JW; Kim S
Cell Signal; 2014 Feb; 26(2):398-408. PubMed ID: 23978400
[TBL] [Abstract] [Full Text] [Related]
10. Urokinase plasminogen activator and its inhibitor type-1 as prognostic factors in differentiated thyroid carcinoma patients.
Horvatic Herceg G; Herceg D; Kralik M; Kulic A; Bence-Zigman Z; Tomic-Brzac H; Bracic I; Kusacic-Kuna S; Prgomet D
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):533-40. PubMed ID: 23835563
[TBL] [Abstract] [Full Text] [Related]
11. The urokinase plasminogen activating system in thyroid cancer: clinical implications.
Baldini E; Sorrenti S; D'Armiento E; Di Matteo FM; Catania A; Ulisse S
G Chir; 2012 Oct; 33(10):305-10. PubMed ID: 23095556
[TBL] [Abstract] [Full Text] [Related]
12. FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma.
Bellelli R; Castellone MD; Garcia-Rostan G; Ugolini C; Nucera C; Sadow PM; Nappi TC; Salerno P; Cantisani MC; Basolo F; Gago TA; Salvatore G; Santoro M
Endocr Relat Cancer; 2012 Oct; 19(5):695-710. PubMed ID: 22919068
[TBL] [Abstract] [Full Text] [Related]
13. In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval.
Ulisse S; Baldini E; Sorrenti S; Barollo S; Prinzi N; Catania A; Nesca A; Gnessi L; Pelizzo MR; Mian C; De Vito C; Calvanese A; Palermo S; Persechino S; De Antoni E; D'Armiento M
Clin Endocrinol (Oxf); 2012 Nov; 77(5):780-6. PubMed ID: 22702340
[TBL] [Abstract] [Full Text] [Related]
14. Effects of ulinastatin and docetaxel on breast cancer invasion and expression of upa, upaR and ERK.
Luo J; Sun X; Gao F; Zhao X; Zhong B; Wang H; Sun Z
J Exp Clin Cancer Res; 2011 Jul; 30(1):71. PubMed ID: 21798065
[TBL] [Abstract] [Full Text] [Related]
15. High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
Ulisse S; Baldini E; Sorrenti S; Barollo S; Gnessi L; Catania A; Pellizzo MR; Nardi F; Mian C; De Antoni E; D'Armiento M; Frati L
J Clin Endocrinol Metab; 2011 Feb; 96(2):504-8. PubMed ID: 21106716
[TBL] [Abstract] [Full Text] [Related]
16. [Beneficial effects of retinoic acid on in vitro invasiveness of human thyroid carcinoma cell lines].
Lan L; Cui D; Luo Y; Shi BY; Deng LL; Zhang GY; Deng W; Wang H
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(34):2407-11. PubMed ID: 21092511
[TBL] [Abstract] [Full Text] [Related]
17. Molecular cloning and characterization of a novel esophageal cancer related gene.
Cui Y; Bi M; Su T; Liu H; Lu SH
Int J Oncol; 2010 Dec; 37(6):1521-8. PubMed ID: 21042721
[TBL] [Abstract] [Full Text] [Related]
18. Clinical and molecular features of papillary thyroid cancer in adolescents and young adults.
Vriens MR; Moses W; Weng J; Peng M; Griffin A; Bleyer A; Pollock BH; Indelicato DJ; Hwang J; Kebebew E
Cancer; 2011 Jan; 117(2):259-67. PubMed ID: 20824721
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of upaR and upa reduces invasion in papillary thyroid carcinoma cells.
Nowicki TS; Kummer NT; Iacob C; Suslina N; Schaefer S; Schantz S; Shin E; Moscatello AL; Tiwari RK; Geliebter J
Laryngoscope; 2010 Jul; 120(7):1383-90. PubMed ID: 20578104
[TBL] [Abstract] [Full Text] [Related]
20. Inhibitory effects of retinoic acid on invasiveness of human thyroid carcinoma cell lines in vitro.
Lan L; Cui D; Luo Y; Shi BY; Deng LL; Zhang GY; Wang H
J Endocrinol Invest; 2009 Oct; 32(9):731-8. PubMed ID: 19509478
[TBL] [Abstract] [Full Text] [Related]
[Next]
